Cognivia and Mayo Clinic Partner to Quantify Patient Behavior

The initiative addresses a long-standing gap in medicine: while biological and clinical factors are rigorously tracked, the human elements that dictate whether a patient follows a care plan or stays in a study remain largely unmeasured. By applying Cognivia’s behavioral intelligence framework, the collaboration seeks to identify risks before they manifest as missed appointments or treatment gaps. This proactive stance is intended to reduce the variability in outcomes that often plagues both experimental drug trials and routine clinical care.

Dominique Demolle, CEO of Cognivia, noted that the industry has historically lacked the tools to systematically act on behavioral drivers. The effort aims to provide care teams with the insights necessary to deploy targeted interventions, ensuring that patients remain engaged throughout their treatment or research journey. Mayo Clinic maintains a financial interest in the technology, with any generated revenue earmarked to support its ongoing mission in research, education, and patient care.